323 related articles for article (PubMed ID: 23971998)
1. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
[TBL] [Abstract][Full Text] [Related]
2. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
3. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
Zhou Y; Wang M; Tong Y; Liu X; Zhang L; Dong D; Shao J; Zhou Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819875168. PubMed ID: 31506061
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
Zhang Z; Dai DQ
World J Gastroenterol; 2019 Mar; 25(10):1224-1237. PubMed ID: 30886505
[TBL] [Abstract][Full Text] [Related]
6. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.
Yan LX; Wu QN; Zhang Y; Li YY; Liao DZ; Hou JH; Fu J; Zeng MS; Yun JP; Wu QL; Zeng YX; Shao JY
Breast Cancer Res; 2011 Jan; 13(1):R2. PubMed ID: 21219636
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
Li S; Xu JJ; Zhang QY
Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
11. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
13. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
[TBL] [Abstract][Full Text] [Related]
14. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
[TBL] [Abstract][Full Text] [Related]
15. miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.
Li Q; Liu J; Jia Y; Li T; Zhang M
Aging (Albany NY); 2020 Jun; 12(11):10246-10258. PubMed ID: 32501811
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
[TBL] [Abstract][Full Text] [Related]
17. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.
Li W; Zang W; Liu P; Wang Y; Du Y; Chen X; Deng M; Sun W; Wang L; Zhao G; Zhai B
Tumour Biol; 2014 Nov; 35(11):10897-904. PubMed ID: 25085587
[TBL] [Abstract][Full Text] [Related]
19. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
20. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]